LIVERMORE, Calif. , Sept. 17, 2025 /PRNewswire/ -- Today, Precision Cell Systems (PCS) announced its official launch following the strategic acquisitions of S2 Genomics and ORFLO, creating a unified company that addresses critical bottlenecks in cell analysis workflows. PCS launches with significant market traction: over 1,000 installed instruments, more than 700 active customers, and a technology portfolio validated by over 500 scientific publications and 25 patents.

"In today's challenging market, many technologies that solve critical problems are stranded because of financial and operational gaps," said Anup Parikh , PhD, CEO of Precision Cell Systems. "We created Precision Cell Systems to solve this problem. Our model provides the commercial and operational infrastructure need

See Full Page